Laddar...
Factor XI as a target for antithrombotic therapy
Anticoagulants currently used in clinical practice to treat thromboembolic disorders are effective but increase the risk of severe bleeding because they target proteins that are essential for normal coagulation (hemostasis). Drugs with better safety profiles are required for prevention and treatment...
Sparad:
| Huvudupphovsmän: | , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
2014
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4167190/ https://ncbi.nlm.nih.gov/pubmed/24886766 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drudis.2014.05.018 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|